Trial intelligence / Profile preview

CHEMO-SIRT in Colorectal Cancer Liver Metastasis

NCT00408551Phase 2Unknown

Sponsor
Goshen Health
Start
Nov 2005
Primary completion
Jun 2009
Modality
Nanoparticles, Device-based Delivery
Countries
1
01

Overview

Phase 2, open-label trial of yttrium-90 resin microspheres in colorectal cancer (CRC), sponsored by Goshen Health. Status: unknown.

02

Drugs

yttrium-90 resin microspheres
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00408551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00408551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call